Montefiore Emergency Department
The Bronx, New York, 10467, United States
NCT Number: NCT01429285
The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.
Looking for future studies?
Notify Me65 year–120 year
All sexes
Interventional
Phase 4
The Bronx, New York, 10467, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
0.5 mg IV hydromorphone followed by an optional 0.5 mg IV dose
Other names: Dilaudid
Attending administers any IV opioid in any dose he chooses
Time frame: 1 hour
Number of patients with "successful treatment" is defined as the number of patients who declined additional pain medication within 1 hour of study entry when asked the question, "Do you want more pain medication?". This measure looks at declining pain medication at either 15 minutes or 60 minutes, whereas 4. Post-Hoc refers only to the answer to the question at the 60 minute mark post-baseline.
Time frame: 60 minutes
Pain intensity is measured on the numerical rating scale (NRS) with scores ranging from 0 ("no pain") to 10 ("worst pain imaginable"). The change in scores over time is calculated by subtracting the score at 60 minutes from the score at baseline (before treatment). These change values were then averaged.
Montefiore Medical Center
Other
Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07728162
Diabetes Mellitus, Disease Attributes
Bolu, Turkey (Türkiye)
View Trial DetailsNCT06598410
Anxiety, Anxiety Disorders
Mersin, Turkey (Türkiye)
View Trial DetailsNCT06109298
Children, Only, Disease Attributes
Mersin, Turkey (Türkiye)
View Trial DetailsNCT06072950
Acute Pain, Disease Attributes
Nijmegen, Gelderland, Netherlands
View Trial Details